CTKB NASDAQ
Cytek Biosciences, Inc.
1W: +17.9%
1M: -14.8%
3M: -10.6%
YTD: -19.5%
1Y: +48.9%
3Y: -42.5%
$4.01
+0.05 (+1.26%)
Weekly Expected Move ±10.3%
$3
$3
$3
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$204M
Revenue
+3.6% YoY
$-74M
Net Income
-557.7% YoY
$-13M
Free Cash Flow
-172.4% YoY
48.2%
Gross Margin
-41.8%
Op. Margin
-42.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-20.1%
ROA-15.4%
ROIC-30.6%
Valuation
P/E-7.0
P/B1.6
EV/EBITDA-14.2
Leverage
Debt/Equity0.10
Current Ratio5.04
Interest Cov.-18.7x
Quality Scores
Piotroski F2/9
Altman Z3.51
Beneish M-3.20